196 related articles for article (PubMed ID: 22117074)
1. Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.
Nunes-Xavier CE; Elson A; Pulido R
J Biol Chem; 2012 Jan; 287(5):3433-44. PubMed ID: 22117074
[TBL] [Abstract][Full Text] [Related]
2. Role of Protein Tyrosine Phosphatase Epsilon (PTP
Lapointe F; Turcotte S; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2019 May; 369(2):270-281. PubMed ID: 30867226
[TBL] [Abstract][Full Text] [Related]
3. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
5. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
6. β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.
Grisanti LA; Talarico JA; Carter RL; Yu JE; Repas AA; Radcliffe SW; Tang HA; Makarewich CA; Houser SR; Tilley DG
J Mol Cell Cardiol; 2014 Jul; 72():39-51. PubMed ID: 24566221
[TBL] [Abstract][Full Text] [Related]
7. Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase.
Wabakken T; Hauge H; Finne EF; Wiedlocha A; Aasheim H
Scand J Immunol; 2002 Aug; 56(2):195-203. PubMed ID: 12121439
[TBL] [Abstract][Full Text] [Related]
8. Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling.
Kraut-Cohen J; Muller WJ; Elson A
J Biol Chem; 2008 Feb; 283(8):4612-21. PubMed ID: 18093973
[TBL] [Abstract][Full Text] [Related]
9. Flotillin-1/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase/mitogen-activated protein kinase signaling.
Amaddii M; Meister M; Banning A; Tomasovic A; Mooz J; Rajalingam K; Tikkanen R
J Biol Chem; 2012 Mar; 287(10):7265-78. PubMed ID: 22232557
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
Faivre EJ; Lange CA
Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.
Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH
Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-Adrenergic Receptor Agonist Brimonidine Stimulates ERK1/2 and AKT Signaling via Transactivation of EGF Receptors in the Human MIO-M1 Müller Cell Line.
Harun-Or-Rashid M; Hallböök F
Curr Eye Res; 2019 Jan; 44(1):34-45. PubMed ID: 30198788
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
15. Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.
Accornero P; Miretti S; Bersani F; Quaglino E; Martignani E; Baratta M
PLoS One; 2012; 7(9):e44982. PubMed ID: 23028720
[TBL] [Abstract][Full Text] [Related]
16. Association of tyrosine phosphatase epsilon with microtubules inhibits phosphatase activity and is regulated by the epidermal growth factor receptor.
Sines T; Granot-Attas S; Weisman-Welcher S; Elson A
Mol Cell Biol; 2007 Oct; 27(20):7102-12. PubMed ID: 17709387
[TBL] [Abstract][Full Text] [Related]
17. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
Wróbel AM; Gregoraszczuk EŁ
Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
[TBL] [Abstract][Full Text] [Related]
18. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
[TBL] [Abstract][Full Text] [Related]
19. Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.
Ren Y; Chen Z; Chen L; Woods NT; Reuther GW; Cheng JQ; Wang HG; Wu J
J Biol Chem; 2007 Dec; 282(50):36463-73. PubMed ID: 17942397
[TBL] [Abstract][Full Text] [Related]
20. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]